Site icon OncologyTube

Hetty Carraway, MD [slides] Immune Innovations in MDS

Hetty Carraway, MD- Hematology and Medical Oncology- Cleveland Clinic

Hetty Carraway, MD, delivers a comprehensive discussion on immune-based and novel strategies to enhance outcomes for patients with myelodysplastic syndromes (MDS). The focus lies on unraveling the intricate relationship between the immune system and MDS pathogenesis, exploring immune interventions like immune checkpoint inhibitors (ICIs), and addressing challenges related to immune manipulation, mutational profiles, and the microenvironment.

REGISTER NOW TO JOIN US AT THESE UPCOMING EVENTS
AML-ALL US – Online content available – https://aml-allus2023.md-education.com/register/
AML-ALL EU – Registration open – https://aml-alleu2023.md-education.com/register/
MPN-MDS EU – registration open – https://mpn-mdseu2023.md-education.com/register/
Register – AML-ALL US Focus Meeting 2023
aml-allus2023.md-education.com

The discourse underscores the necessity for continuous research, particularly within the context of an aging population and its implications for health outcomes. Hetty Carraway also delves into potential therapeutic avenues involving specific mutation targeting and inflammation pathways, emphasizing the nuanced interplay between genetics and the immune landscape in shaping disease progression. The overarching goal is to uncover strategies that disrupt clonal evolution and enhance treatment options, all presented by Hetty Carraway, MD.

Exit mobile version